What is King Pharmaceuticals's net income?

King Pharmaceuticals (KG) reported net income of -$7.43M in Q1 2026.

How has King Pharmaceuticals's net income changed year-over-year?

King Pharmaceuticals's net income decreased by 1786.0% year-over-year, from -$394K to -$7.43M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

King Pharmaceuticals KG Net Income

Net Income at other companies

Arch Capital GroupACGL

$1.05B+82.4%

Everest GroupEG

$653M+211%

SiriusPointSPNT

$102.2M+65.9%

KKR & Co.KKR

$405.23M+318%

Skyward Specialty Insurance Group, Inc.SKWD

$49.73M+18.2%

Tiptree Inc.TIPT

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's net income?: King Pharmaceuticals (KG) reported net income of -$7.43M in Q1 2026.
How has King Pharmaceuticals's net income changed year-over-year?: King Pharmaceuticals's net income decreased by 1786.0% year-over-year, from -$394K to -$7.43M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.